% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board


    I just can't believe that you Amgen guys apperently know absolutely nothing about this target/drug at present in phase2 trials..

    This target will be worth billions of $$ for Amgen in the long run, and will within a few years totally replace Enbrel as an inflammation drug.

    IL15 plays a pivotal role when it comes to diseases like:
    Blood transfusion
    Cancers, primarily lymphoma

    IL15 is the quarterback when it comes to inflammation and controls productions of A WIDE RANGE of toxic mechanisms like for instance TNF and inflammatory T-cells.

    At Amgen R&D day March 23rd in New York you will hear more about this....

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
170.76-0.75(-0.44%)Aug 30 4:00 PMEDT